These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 9973442

  • 21. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D.
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [Abstract] [Full Text] [Related]

  • 22. Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
    Seth A, Markee J, Hoering A, Sevin A, Sabath DE, Schmitz JE, Kuroda MJ, Lifton MA, Hirsch MS, Collier AC, Letvin NL, McElrath MJ.
    J Infect Dis; 2001 Mar 01; 183(5):722-9. PubMed ID: 11181148
    [Abstract] [Full Text] [Related]

  • 23. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T.
    Viral Immunol; 2005 Mar 01; 18(4):627-36. PubMed ID: 16359229
    [Abstract] [Full Text] [Related]

  • 24. Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice.
    Kuribayashi H, Wakabayashi A, Shimizu M, Kaneko H, Norose Y, Nakagawa Y, Wang J, Kumagai Y, Margulies DH, Takahashi H.
    Biochem Biophys Res Commun; 2004 Apr 02; 316(2):356-63. PubMed ID: 15020225
    [Abstract] [Full Text] [Related]

  • 25. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y, Kaneko S, Takizawa H, Kikumoto Y, Takano M, Himeda Y, Kobayashi K.
    J Med Virol; 2003 May 02; 70(1):51-61. PubMed ID: 12629644
    [Abstract] [Full Text] [Related]

  • 26. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
    Arrode G, Finke JS, Zebroski H, Siegal FP, Steinman RM.
    Eur J Immunol; 2005 Jan 02; 35(1):159-70. PubMed ID: 15580653
    [Abstract] [Full Text] [Related]

  • 27. Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120.
    Höhn H, Kortsik C, Tully G, Nilges K, Necker A, Freitag K, Neukirch C, Galle P, Löhr H, Maeurer MJ.
    Eur J Immunol; 2003 Jun 02; 33(6):1613-23. PubMed ID: 12778479
    [Abstract] [Full Text] [Related]

  • 28. Interdisciplinary analysis of HIV-specific CD8+ T cell responses against variant epitopes reveals restricted TCR promiscuity.
    Hoof I, Pérez CL, Buggert M, Gustafsson RK, Nielsen M, Lund O, Karlsson AC.
    J Immunol; 2010 May 01; 184(9):5383-91. PubMed ID: 20363973
    [Abstract] [Full Text] [Related]

  • 29. Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
    Hoffmann TK, Donnenberg AD, Finkelstein SD, Donnenberg VS, Friebe-Hoffmann U, Myers EN, Appella E, DeLeo AB, Whiteside TL.
    Cancer Res; 2002 Jun 15; 62(12):3521-9. PubMed ID: 12067999
    [Abstract] [Full Text] [Related]

  • 30. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    Ho HN, Hultin LE, Mitsuyasu RT, Matud JL, Hausner MA, Bockstoce D, Chou CC, O'Rourke S, Taylor JM, Giorgi JV.
    J Immunol; 1993 Apr 01; 150(7):3070-9. PubMed ID: 8454874
    [Abstract] [Full Text] [Related]

  • 31. Characterization of HLA-B57-restricted human immunodeficiency virus type 1 Gag- and RT-specific cytotoxic T lymphocyte responses.
    Klein MR, van der Burg SH, Hovenkamp E, Holwerda AM, Drijfhout JW, Melief CJ, Miedema F.
    J Gen Virol; 1998 Sep 01; 79 ( Pt 9)():2191-201. PubMed ID: 9747728
    [Abstract] [Full Text] [Related]

  • 32. Antagonism of cytotoxic T lymphocyte-mediated lysis by natural HIV-1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides.
    Sewell AK, Harcourt GC, Goulder PJ, Price DA, Phillips RE.
    Eur J Immunol; 1997 Sep 01; 27(9):2323-9. PubMed ID: 9341776
    [Abstract] [Full Text] [Related]

  • 33. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
    Kundu SK, Merigan TC.
    AIDS; 1992 Jul 01; 6(7):643-9. PubMed ID: 1354446
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxic T cells in HIV2 seropositive Gambians. Identification of a virus-specific MHC-restricted peptide epitope.
    Gotch F, McAdam SN, Allsopp CE, Gallimore A, Elvin J, Kieny MP, Hill AV, McMichael AJ, Whittle HC.
    J Immunol; 1993 Sep 15; 151(6):3361-9. PubMed ID: 7690804
    [Abstract] [Full Text] [Related]

  • 35. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD.
    J Immunol; 1996 Apr 01; 156(7):2616-23. PubMed ID: 8786327
    [Abstract] [Full Text] [Related]

  • 36. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
    López M, Soriano V, Lozano S, Martinez P, Sempere J, González-Lahoz J, Benito J.
    AIDS Res Hum Retroviruses; 2006 Sep 01; 22(9):884-92. PubMed ID: 16989614
    [Abstract] [Full Text] [Related]

  • 37. Recognition of variant HIV-1 epitopes from diverse viral subtypes by vaccine-induced CTL.
    McKinney DM, Skvoretz R, Livingston BD, Wilson CC, Anders M, Chesnut RW, Sette A, Essex M, Novitsky V, Newman MJ.
    J Immunol; 2004 Aug 01; 173(3):1941-50. PubMed ID: 15265928
    [Abstract] [Full Text] [Related]

  • 38. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y, Miura H, Tomiyama H, Kawana-Tachikawa A, Takiguchi M, Kojima A, Nagai Y, Iwamoto A, Matsuda Z, Ariyoshi K.
    J Virol; 2004 Feb 01; 78(3):1324-32. PubMed ID: 14722287
    [Abstract] [Full Text] [Related]

  • 39. Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.
    Hossain MS, Tomiyama H, Inagawa T, Ida S, Oka S, Takiguchi M.
    AIDS Res Hum Retroviruses; 2003 Jun 01; 19(6):503-10. PubMed ID: 12882660
    [Abstract] [Full Text] [Related]

  • 40. Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes in rhesus monkeys.
    Yasutomi Y, Palker TJ, Gardner MB, Haynes BF, Letvin NL.
    J Immunol; 1993 Nov 01; 151(9):5096-105. PubMed ID: 7691965
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 38.